Claremont BioSolutions has entered into a strategic partnership and technology development agreement with In“Q“Tel to accelerate commercialization of its Prep-on-a-Chip sample preparation platform, according to an In-Q-Tel statement.
Claremont has created entirely disposable sample preparation devices that efficiently lyse any cell type and simultaneously extract DNA or RNA using the mechanical energy of micromotors used in the cell phone industry.
“Claremont BioSolutions has taken an innovative approach to nucleic acid extraction,“ said Syd Ulvick, senior vice president in charge of physical and biological technologies at IQT.
He added, “We believe that further development of this technology will provide valuable capabilities for both the public and private sector.“
The battery-powered devices can extract nucleic acids from cells in less than five minutes.
“The In-Q-Tel investment will aid us in our mission to multiplex and automate the handling of the devices, completing our development of the Prep-on-a-Chip platform,“ said Claremont CEO Gary Blackburn.